MEDS — TRXADE HEALTH INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $7.7M | -71.9% | -$43.4M | — | — | 16.2% | 396.8% | — | — | — | — |
Revenue YoY trend Net margin trend
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
MEDS (TRXADE HEALTH INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 15 funds have reported positions historically, with the sum of their latest reported stakes valued at $739.48K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of TRXADE HEALTH INC (MEDS) include Morgan Stanley, Vanguard Group, Renaissance Technologies, ranked by reported 13F value among the 15 institutional holders on this page.
MEDS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2024 | 1 | 357 | $3.99K | +0.0% |
| Q2 2024 | 5 | 27.23K | $303.87K | -44.8% |
| Q1 2024 | 8 | 70.38K | $721.09K | -43.8% |
| Q4 2023 | 5 | 2.58K | $14.55K | +54.9% |
| Q3 2023 | 5 | 1.67K | $14.20K | -91.7% |
| Q2 2023 | 4 | 15.69K | $204.72K | +16.1% |
| Q1 2023 | 4 | 85.89K | $25.34K | -59.3% |
| Q4 2022 | 5 | 212.15K | $84.45K | -5.8% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q4 2022 → Q3 2024); the largest single-quarter swing was Q3 2023 (-91.7%).
Top Institutional Holders (Q3 2024) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 357 | $3.99K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2024 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.55K | $162.50K | 0.00% | Hold | |
| 11.70K | $130.69K | 0.00% | Reduce | |
| 622 | $6.95K | 0.00% | Reduce | |
| 357 | $3.66K | 0.00% | Hold | |
| 7 | $78 | 0.00% | New |
Q1 2024 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 33.38K | $342.00K | 0.00% | New | |
| 14.55K | $148.97K | 0.00% | New | |
| 10.62K | $109.00K | 0.01% | New | |
| 10.20K | $104.43K | 0.00% | New | |
| 1.02K | $10.44K | 0.00% | Reduce | |
| 357 | $3.66K | 0.00% | Hold | |
| 246 | $2.52K | 0.00% | New | |
| 8 | $82 | 0.00% | Hold |
Q4 2023 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.10K | $10.91K | 0.00% | Add | |
| 357 | $3.00K | 0.00% | Hold | |
| 100 | $520 | 0.00% | Reduce | |
| 15 | $78 | 0.00% | Hold | |
| 8 | $42 | 0.00% | Add |
Q3 2023 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.09K | $7.66K | 0.00% | New | |
| 357 | $5.00K | 0.00% | New | |
| 200 | $1.41K | 0.00% | New | |
| 15 | $105 | 0.00% | New | |
| 3 | $21 | 0.00% | Reduce |
Q2 2023 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.87K | $180.96K | 0.00% | New | |
| 900 | $11.74K | 0.00% | New | |
| 884 | $11.54K | 0.00% | New | |
| 36 | $470 | 0.00% | Add |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 15 funds)
| Fund | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blue Trust, Inc. | 357 | 357 | 357 | 357 | 357 | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | 11.70K | 33.38K | — | — | — | — | — | — | — | — | 21.60K | — | — | 110.70K | 40.10K |
| Vanguard Group | — | 14.55K | 14.55K | — | — | — | 39.63K | 158.74K | 179.27K | 170.54K | 170.74K | 170.74K | 170.74K | 138.63K | — | — |
| Virtu Financial LLC | — | — | 10.62K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | — | 10.20K | — | — | — | 42.06K | 42.06K | 42.06K | 42.06K | 42.06K | 42.06K | 42.06K | — | — | — |
| Tower Research Capital LLC (TRC) | — | 622 | 1.02K | 2.10K | 1.09K | — | — | — | — | — | — | — | — | — | — | — |
| PNC Financial Services | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.03K | 1.03K |
| UBS Group AG | — | — | 246 | — | — | 900 | — | 11.31K | 3.84K | 375 | 3.07K | — | 5.42K | — | — | — |
| Qube Research & Technologies Ltd | — | — | — | 100 | 200 | — | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | — | — | 8 | 8 | 3 | 36 | 31 | 30 | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | 7 | — | 15 | 15 | — | — | — | — | — | — | 6 | 271 | — | — | — |
| Citigroup Inc | — | — | — | — | — | — | 4.17K | — | — | — | 300 | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | 13.20K | 18.18K | 25.76K | — | — | — | — |
| Morgan Stanley | — | — | — | — | — | 13.87K | — | 4 | — | — | — | 5.25K | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | 884 | — | — | — | — | — | — | — | — | — | — |
FAQ
Which funds hold MEDS?
15 funds have reported positions in MEDS across five years of 13F filings; the sum of their latest reported stakes is $739.48K.
Who are the top institutional holders of MEDS?
The largest 13F holders are Morgan Stanley, Vanguard Group, Renaissance Technologies, Virtu Financial LLC, Geode Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of TRXADE HEALTH INC?
The major shareholders of TRXADE HEALTH INC (MEDS) by reported 13F value are Morgan Stanley, Vanguard Group, Renaissance Technologies, Virtu Financial LLC, Geode Capital Management, among 15 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.